Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 117 (14), 3921-8

Tregs Prevent GVHD and Promote Immune Reconstitution in HLA-haploidentical Transplantation

Affiliations
Clinical Trial

Tregs Prevent GVHD and Promote Immune Reconstitution in HLA-haploidentical Transplantation

Mauro Di Ianni et al. Blood.

Abstract

Hastening posttransplantation immune reconstitution is a key challenge in human leukocyte antigen (HLA)-haploidentical hematopoietic stem-cell transplantation (HSCT). In experimental models of mismatched HSCT, T-regulatory cells (Tregs) when co-infused with conventional T cells (Tcons) favored posttransplantation immune reconstitution and prevented lethal graft-versus-host disease (GVHD). In the present study, we evaluated the impact of early infusion of Tregs, followed by Tcons, on GVHD prevention and immunologic reconstitution in 28 patients with high-risk hematologic malignancies who underwent HLA-haploidentical HSCT. We show for the first time in humans that adoptive transfer of Tregs prevented GVHD in the absence of any posttransplantation immunosuppression, promoted lymphoid reconstitution, improved immunity to opportunistic pathogens, and did not weaken the graft-versus-leukemia effect. This study provides evidence that Tregs are a conserved mechanism in humans.

Similar articles

See all similar articles

Cited by 367 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback